{"id":"W3160346821","doi":"10.1038/s41375-021-01260-y","title":"Long-term treatment-free remission in patients with chronic myeloid leukemia after second-line nilotinib: ENESTop 5-year update","year":2021,"lang":"en","type":"article","venue":"Leukemia","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Novartis Pharmaceuticals Corporation","keywords":"Nilotinib; Medicine; Myeloid leukemia; Internal medicine; Adverse effect; Tyrosine-kinase inhibitor; Imatinib; Surgery; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002369438,0.0004189706,0.001671268,0.0010289,0.0001924992,0.001510124,0.0008378765,0.000776579,0.00177999],"category_scores_gemma":[0.00482743,0.0001710986,0.001336308,0.001378504,0.0002438377,0.001551116,0.0006966219,0.001885806,0.0004319081],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001087261,"about_ca_system_score_gemma":0.001440773,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001543177,"about_ca_topic_score_gemma":0.007509603,"domain_scores_codex":[0.99937,0.0001388691,0.0001697379,0.00007977928,0.0001701241,0.00007149493],"domain_scores_gemma":[0.9968054,0.001573541,0.000915483,0.00005252384,0.0004317838,0.0002212975],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.001358336,0.0001294805,0.01084381,0.007437828,0.0008632732,0.0001234344,0.00007267655,0.0005464713,0.0003992163,0.0009970855,0.04453666,0.9326918],"study_design_scores_gemma":[0.001330155,0.001839146,0.08201896,0.0212432,0.006743752,0.002441631,0.0002549959,0.0008980097,0.0007698993,0.002185593,0.8801701,0.0001046588],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.004558986,0.9874155,0.0003986179,0.00340117,0.0007837703,0.00002007388,0.001029076,0.00003643579,0.002356418],"genre_scores_gemma":[0.04499133,0.9387794,0.001430254,0.00707237,0.002164159,0.0001103142,0.004135365,0.0000245461,0.001292177],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.002369438,"threshold_uncertainty_score":0.01253092,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.009310910288651317,"score_gpt":0.2404248487691427,"score_spread":0.2311139384804914,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}